US Patent Issued to UCL Business on July 29 for "Fabry disease gene therapy" (British Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,268, issued on July 29, was assigned to UCL Business LTD (London).

"Fabry disease gene therapy" was invented by Amit Nathwani (London) and Deepak Raj (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "There is described a nucleic acid molecule comprising a nucleotide sequence encoding for a functional Alpha-galactosidase A protein wherein the nucleotide sequence has at least 85% identity to the sequence of SEQ ID NO. 1. Also described is a vector, host cell or transgenic animal comprising the nucleic acid molecule; and a pharmaceutical composition comprising the nucleic acid molecule or the vector. Further, the use of the nucleic acid molecule i...